Cellosaurus logo
expasy logo

Cellosaurus XP6BE (CVCL_F599)

[Text version]
Cell line name XP6BE
Synonyms XP6 BE; Xeroderma Pigmentosum 6 BEthesda; Cay Wen; GM10430; GM 10430
Accession CVCL_F599
Secondary accession CVCL_U683
Resource Identification Initiative To cite this cell line use: XP6BE (RRID:CVCL_F599)
Comments Population: Caucasian.
Derived from site: In situ; Skin; UBERON=UBERON_0002097.
Cell type: Fibroblast of skin; CL=CL_0002620.
Sequence variations
  • Mutation; HGNC; 3434; ERCC2; Simple; p.Gly36_Arg61del; Zygosity=Heterozygous (Coriell=GM10430).
  • Mutation; HGNC; 3434; ERCC2; Simple; p.Arg683Trp (c.2047C>T); ClinVar=VCV000016793; Zygosity=Heterozygous (Coriell=GM10430).
Disease Xeroderma pigmentosum, complementation group D (NCIt: C3967)
Xeroderma pigmentosum (ORDO: Orphanet_910)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Children:
CVCL_F505 (XP6BE(SV))
Sex of cell Female
Age at sampling 19Y
Category Finite cell line
Publications

PubMed=4811796; DOI=10.7326/0003-4819-80-2-221
Robbins J.H., Kraemer K.H., Lutzner M.A., Festoff B.W., Coon H.G.
Xeroderma pigmentosum. An inherited disease with sun sensitivity, multiple cutaneous neoplasms, and abnormal DNA repair.
Ann. Intern. Med. 80:221-248(1974)

PubMed=273925; DOI=10.1073/pnas.75.4.1984; PMCID=PMC392467
Andrews A.D., Barrett S.F., Robbins J.H.
Xeroderma pigmentosum neurological abnormalities correlate with colony-forming ability after ultraviolet radiation.
Proc. Natl. Acad. Sci. U.S.A. 75:1984-1988(1978)

PubMed=643622; DOI=10.1093/nar/5.3.951; PMCID=PMC342035
Kuhnlein U., Lee B., Penhoet E.E., Linn S.M.
Xeroderma pigmentosum fibroblasts of the D group lack an apurinic DNA endonuclease species with a low apparent Km.
Nucleic Acids Res. 5:951-960(1978)

PubMed=6409440; DOI=10.1093/carcin/4.7.911
Smith P.J., Greene M.H., Adams D., Paterson M.C.
Abnormal responses to the carcinogen 4-nitroquinoline 1-oxide of cultured fibroblasts from patients with dysplastic nevus syndrome and hereditary cutaneous malignant melanoma.
Carcinogenesis 4:911-916(1983)

PubMed=3922833; DOI=10.20772/cancersci1985.76.3_162
Fujiwara Y., Satoh Y.
Assignment of two Japanese xeroderma pigmentosum patients to complementation group D and their characteristics.
Jpn. J. Cancer Res. 76:162-166(1985)

CLPUB00447
Mulivor R.A., Suchy S.F.
1992/1993 catalog of cell lines. NIGMS human genetic mutant cell repository. 16th edition. October 1992.
(In misc. document) Institute for Medical Research (Camden, N.J.) NIH 92-2011; pp.1-918; National Institutes of Health; Bethesda; USA (1992)

PubMed=1372108; DOI=10.1016/0921-8777(92)90072-b
Johnson R.T., Squires S.
The XPD complementation group. Insights into xeroderma pigmentosum, Cockayne's syndrome and trichothiodystrophy.
Mutat. Res. 273:97-118(1992)

PubMed=30165384; DOI=10.1093/nar/gky774; PMCID=PMC6182131
Sabatella M., Theil A.F., Ribeiro-Silva C., Slyskova J., Thijssen K., Voskamp C., Lans H., Vermeulen W.
Repair protein persistence at DNA lesions characterizes XPF defect with Cockayne syndrome features.
Nucleic Acids Res. 46:9563-9577(2018)

Cross-references
Cell line collections (Providers) ATCC; CRL-1157 - Discontinued
Coriell; GM10430
Cell line databases/resources CLO; CLO_0028648
Biological sample resources BioSample; SAMN00800015
Encyclopedic resources Wikidata; Q54844449
Entry history
Entry creation11-Feb-2013
Last entry update02-May-2024
Version number19